Fakultni Nemocnice Motol A Homolka
Fakultni Nemocnice Motol A Homolka is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
International cooperative prospective study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine
Sponsor GPOH gGmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
An international prospective umbrella trial for children with atypical teratoid/rhabdoid tumours (ATRT) including a randomized phase III study evaluating the non-inferiority of three courses of high-dose chemotherapy (HDCT) compared to focal radiotherapy as consolidation therapy
Sponsor GPOH gGmbH
- Start (EU)
- Latest update
- Estimated end
AIEOP-BFM ALL 2025 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia
Sponsor Universitaetsklinikum Schleswig-Holstein AöR
- Start (EU)
- Not reported
- Latest update
- Estimated end
Phase III Clinical Trial for CPX-351 in Myeloid Leukemia in Children with Down Syndrome 2018
Sponsor GPOH gGmbH
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Fakultni Nemocnice Motol A Homolka?
The 2026-10-09 snapshot links Fakultni Nemocnice Motol A Homolka to 4 distinct CTIS trials. Recorded services include Clinical monitoring, Data management, Project management, Investigator recruitment, among 11 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Fakultni Nemocnice Motol A Homolka?
The most frequently recorded therapeutic areas are Haematological Malignancies, Neurology, Solid Tumor Oncology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Fakultni Nemocnice Motol A Homolka conducted?
The linked trials record locations in 16 countries, including Germany, Austria, Belgium, Czechia, Italy. These are trial locations, not confirmed office locations or countries where Fakultni Nemocnice Motol A Homolka delivered services.
What can this page tell me about Fakultni Nemocnice Motol A Homolka's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Fakultni Nemocnice Motol A Homolka. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Fakultni Nemocnice Motol A Homolka